FindTrial
Sign In

A Study to Determine the benefit of the use of Risk Stratification scores - MEESI and EHMRG, for assessment of 7 day and 30 day death rates, in patients with Acute Heart Failure , in an Indian Population.

A Study in Usefulness of MEESI score and EHMRG score in Predicting the Short Term Mortality in Acute Heart Failure in Indian Population. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061887
Enrollment
128
Registered
2024-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I509- Heart failure, unspecified

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr Satyajeet Rakh
Lead Sponsor
Dr Nithin Bhat
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age > 18 years 2) Diagnosed as acute heart failure based upon clinical diagnostic criteria ( Framingham Heart Failure diagnostic criteria ) and European society of cardiology diagnostic algorithm

Exclusion criteria

Exclusion criteria: 1) patients with ST-Elevation Myocardial Infarction 2) patients undergoing dialysis

Design outcomes

Primary

MeasureTime frame
1) 7 day mortality - yes or no 2) 30 day mortality - yes or noTimepoint: 1) 7 day mortality - yes or no 2) 30 day mortality - yes or no—

Secondary

MeasureTime frame
nilTimepoint: 15 september 2023- 1 june 2024—

Countries

India

Contacts

Public ContactDr Nithin Bhat

Kasturba Medical College

nithinkbhat@gmail.com9008576103

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026